Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study
Abstract Background Hepatitis C virus (HCV) reinfection following successful treatment threatens the achievement of HCV elimination. The primary aim of this study is to assess reinfection rate three years after sustained virologic response (SVR) in people who inject drugs (PWID) that are on opioid a...
Saved in:
Main Authors: | Fernando Chacón (Author), Luis Morano (Author), Jordi Navarro (Author), Rafael Granados (Author), Josep Mª Llibre (Author), Pablo Ryan (Author), Teresa Aldámiz-Echevarria (Author), Luz Martín Carbonero (Author), Marc Puigvehí (Author), Imma Clotet-Codina (Author), Nuria Sanchez-Vega (Author), Enrique Vacas (Author), Oscar Rincón (Author), Juan Berenguer (Author), Javier Crespo (Author), Carlos Roncero (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of antiviral drugs to reduce COVID-19 transmission
by: Oriol Mitjà, et al.
Published: (2020) -
COVID-19: Is Reinfection a Threat or Not?
by: Julián Felipe PORRAS VILLAMIL, et al.
Published: (2020) -
The Recurrence of Infection: Recrudescence Versus Reinfection
by: Jong Kyu Park
Published: (2023) -
Reinfection, immunity and prevention of transmission of COVID-19
by: Humberto Guanche Garcell, et al.
Published: (2021) -
Intervenciones para Aumentar la Asistencia a las Pruebas de Detección de Retinopatía Diabética
by: Pedro Gutiérrez Moraño, et al.
Published: (2019)